Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
RMD Open|September 29, 2017
Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologicKatie L Druce, Kundan Iqbal, Kath D Watson, et al.
Annals of the Rheumatic Diseases|January 18, 2002
Musculoskeletal pain is more generalised among people from ethnic minorities than among white people in Greater ManchesterT R Allison, D P M Symmons, T Brammah, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 16, 2019
A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid ArthritisGeorge D Kitas, Peter Nightingale, Jane Armitage, et al.
Arthritis and Rheumatism|July 27, 2006
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics RegisterW G Dixon, K Watson, M Lunt, et al.
BMC Musculoskeletal Disorders|June 1, 2010
Influence of arthritis and non-arthritis related factors on areal bone mineral density (BMDa) in women with longstanding inflammatory polyarthritis: a primary care based inception cohortStephen R Pye, Tarnya Marshall, Karl Gaffney, et al.
The Journal of Rheumatology|December 17, 2011
Effectiveness of rituximab in patients with rheumatoid arthritis: observational study from the British Society for Rheumatology Biologics RegisterMoetaza M Soliman, Kimme L Hyrich, Mark Lunt, et al.
Annals of the Rheumatic Diseases|June 29, 2010
The relationship between post-onset pregnancy and functional outcome in women with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis RegisterE M Camacho, T M Farragher, M Lunt, et al.
Arthritis Care & Research|June 11, 2010
Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics RegisterW G Dixon, K D Watson, M Lunt, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritisJarrod Franklin, Tracey M Farragher, Mark Lunt, et al.
Arthritis and Rheumatism|September 1, 2007
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics RegisterW G Dixon, K D Watson, M Lunt, et al.
Pageof 18